Mediterranean diet may lower risk of pregnancy complications

Embargoed until: Publicly released: 2022-12-23 03:00

International

Photo by Louis Hansel on Unsplash

Following a Mediterranean diet, a diet based on foods traditionally eaten in countries including France, Spain, Greece, and Italy, is associated with a lower risk of a range of pregnancy complications according to international researchers. The team looked at the diets of about 10,000 women around conception and whether they went on to have adverse pregnancy outcomes including preeclampsia/eclampsia, gestational hypertension and diabetes, preterm birth and stillbirth. The researchers say those whose diet was highly similar to a Mediterranean diet had 21% lower risk of any adverse pregnancy outcome compared to those whose diet was highly different from a Mediterranean diet.

Media release

From:

Attachments

Note: Not all attachments are visible to the general public. Research URLs will go live after the embargo ends.

Research JAMA, Web page The URL will go live after the embargo ends

Journal/
conference: JAMA Network Open

Research:Paper

Organisation/s: Columbia University, USA

Funder: This work was supported by NIH/Office of Research onWomen’s Health (ORWH) Building Interdisciplinary Research Careers inWomen’s Health (BIRCWH) grant NIH K12HD043441 and by cooperative agreement funding from the NHLBI and the Eunice Kennedy Shriver National Institute of Child Health and Human Development: grants U10-HL119991, U10-HL119989, U10-HL120034, U10-HL119990, U10-HL120006, U10-HL119992, U10-HL120019, U10-HL119993, U10-HL120018, and U01HL145358. The study was also supported by grant funding from the Eunice Kennedy Shriver National Institute of Child Health and Human Development: grants U10 HD063036, U10 HD063072, U10 HD063047, U10 HD063037, U10 HD063041, U10 HD063020, U10 HD063046, U10 HD063048, and U10 HD063053. Support was also provided by the NIH/ORWH through grant U10-HL119991; Office of Behavioral and Social Sciences Research through grants U10-HL119991 and U10-HL119992; and the National Center for Advancing Translational Sciences through grants UL-1-TR000124, UL-1- TR000153, UL-1-TR000439, and UL-1-TR001108; and grant 1U54AG065141-01 from the NIH/National Institute on Aging, the Barbra StreisandWomen’s Cardiovascular Research and Education Program, and the Erika J. Glazer Women’s Heart Research Initiative, Cedars-Sinai Medical Center, Los Angeles. Dr Makarem was supported by NIH/NHLBI grant R00-HL148511 and American Heart Association grant 855050. Dr Bello was supported by grants K23HL136853 and R01HL153382 from the NIH/NHLBI. Dr Miller was supported by grants K23NS107645 and R01NS122815 from the NIH/National Institute of Neurological Disorders and Stroke and by the Gerstner Family Foundation.

Media Contact/s

Contact details are only visible to registered journalists.